Log In
BCIQ
Print this Print this
 

Instiladrin, rAd-IFN

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionAdenovirus serotype 5 (Ad5) vector containing interferon (IFN) alfa-2b
Molecular Target Interferon (IFN) alpha
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPhase I
Standard IndicationBladder cancer
Indication DetailsTreat bladder cancer
Regulatory Designation
PartnerFKD Therapies Oy

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/26/2011

Undisclosed

0

0

Get a free BioCentury trial today